CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
OTCPharm PAO Company Snapshot
OTCPharm PAO operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares OTCPharm PAO with three other pharmaceutical manufacturers in Europe: Swedish Orphan Biovitrum AB (publ) of Sweden (2016 sales of 4.50 billion Swedish Kronor [US$558.67 million] of which 41% was Haemophilia: Elocta), Sopharma AD of Bulgaria (885.38 million Bulgarian Lev [US$551.64 million] of which 51% was Tablets), and Vetoquinol Sa which is based in France (350.35 million Euro [US$426.74 million] of which 76% was Europe).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
OTCPharm PAO
  Stock Performance Chart for OTCPharm PAO
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 18.30
(Figures in Russian Rubles)
1 Week 4.0%   13 Weeks 3.4%  
4 Weeks 5.8%   52 Weeks 1.9%  
 
OTCPharm PAO Key Data:
  Ticker: OTCP Country: Russian Federation
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 26,760,604,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Russian Rubles Market Cap: 2,661,235,996
  Fiscal Yr Ends: December Shares Outstanding: 145,422,732
  Share Type: Ordinary Closely Held Shares: 133,658,033
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.